New York, NY (PRWEB) March 15, 2012
The Lymphoma Research Foundation (LRF), the nation’s largest non-profit organization devoted exclusively to funding lymphoma research and to serving those touched by the disease, is pleased to announce a new financial aid program for people with T-cell lymphoma. The LRF T-Cell Lymphoma Transportation Assistance Fund provides financial assistance to T-cell lymphoma patients who are uninsured or have adequate medical insurance, but struggle to pay for transportation costs to travel to and from treatment. The program is supported through a charitable contribution from Celgene Corporation.
Lymphoma – the most common type of blood cancer – comprises more than 67 subtypes of two related cancers that affect the lymphatic system, Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). T-cell lymphomas account for approximately 15 percent of all NHL cases in the United States. There are several different types of T-cell lymphoma, some of which are extremely rare, occurring in only a few patients per year throughout the world.
“Research indicates that the financial burdens of cancer care make it difficult for patients to focus on their recovery,” said Diane Blum, LRF Chief Executive Officer. “The Foundation is dedicated to assisting patients facing these challenges and we are pleased to offer this new resource to people with T-cell lymphoma.”
Applicants applying for the T-Cell Lymphoma Transportation Assistance Fund Grant must complete an application, demonstrate financial need, and currently be undergoing treatment for T-cell lymphoma. To request an application, patients and healthcare providers should contact LRF at Helpline(at)lymphoma(dot)org or 800-500-9976. For more information about T-cell lymphoma and LRF’s disease-specific resources and programs, visit lymphoma.org.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit lymphoma organization devoted exclusively to funding innovative research and providing people with lymphoma and healthcare professionals with critical information on the disease. To date, LRF has awarded more than $47 million in lymphoma-specific research.
For additional information on LRF’s programs and services, visit lymphoma.org.